Skip to main content
XOMA Royalty Corporation (XOMA)
NASDAQ: XOMA · Real-Time Price · USD
41.25
+0.39 (0.95%)
Apr 29, 2026, 1:20 PM EDT - Market open

XOMA Royalty Revenue

In the year 2025, XOMA Royalty had annual revenue of $52.15M with 83.06% growth. XOMA Royalty had revenue of $13.76M in the quarter ending December 31, 2025, with 57.87% growth.

Revenue (ttm)
$52.15M
Revenue Growth
+83.06%
P/S Ratio
9.37
Revenue / Employee
$3,724,929
Employees
14
Market Cap
491.52M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202552.15M23.66M83.06%
Dec 31, 202428.49M23.73M498.72%
Dec 31, 20234.76M-1.27M-21.06%
Dec 31, 20226.03M-32.13M-84.21%
Dec 31, 202138.16M8.78M29.86%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
MiMedx Group 418.63M
Valneva SE 205.07M
4D Molecular Therapeutics 85.21M
ADC Therapeutics 81.36M
Fulcrum Therapeutics 80.00M
Verastem 30.91M
Upstream Bio 2.85M
Revenue Rankings

XOMA News

More News